Brand Name | Status | Last Update |
---|---|---|
liqrev | New Drug Application | 2024-05-28 |
revatio | New Drug Application | 2024-12-18 |
sildenafil | ANDA | 2025-03-13 |
sildenafil citrate | ANDA | 2025-03-20 |
sildenafil for oral suspension | ANDA | 2020-08-15 |
viagra | New Drug Application | 2023-11-17 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
pulmonary hypertension | EFO_0001361 | D006976 | I27.20 |
vasculogenic impotence | EFO_1001234 | D018783 | — |
Expiration | Code | ||
---|---|---|---|
SILDENAFIL CITRATE, REVATIO, VIATRIS | |||
2026-01-31 | M-287 |
Code | Description |
---|---|
S0090 | Sildenafil citrate, 25 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | 1 | 3 | — | 4 | 3 | 11 |
Hypertension | D006973 | EFO_0000537 | I10 | — | 2 | 6 | 2 | 1 | 11 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | 1 | 7 | 2 | — | 10 |
Pulmonary arterial hypertension | D000081029 | — | — | 1 | 1 | 3 | 1 | 1 | 7 |
Fibrosis | D005355 | — | — | — | — | 1 | 1 | — | 2 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | 1 | — | 1 | — | 2 |
Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | — | — | 1 | 1 | — | 2 |
Pulmonary fibrosis | D011658 | — | J84.10 | — | — | 1 | 1 | — | 2 |
Depression | D003863 | — | F33.9 | — | — | — | 2 | — | 2 |
Connective tissue diseases | D003240 | EFO_1001986 | M35 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Heart failure | D006333 | EFO_0003144 | I50 | — | — | 4 | — | — | 4 |
Familial primary pulmonary hypertension | D065627 | — | I27.0 | — | — | 3 | — | 1 | 4 |
Diastolic heart failure | D054144 | EFO_1000899 | I50.30 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic hyperplasia | D011470 | EFO_0000284 | N40 | 1 | 1 | — | — | — | 2 |
Hyperplasia | D006965 | EFO_0000536 | — | 1 | 1 | — | — | — | 2 |
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | 1 | — | — | — | 1 |
Insulin resistance | D007333 | EFO_0002614 | E88.819 | 1 | 1 | — | — | — | 1 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | 1 | — | — | — | 1 |
Lower urinary tract symptoms | D059411 | EFO_0008008 | — | — | 1 | — | — | — | 1 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | 1 | — | — | — | 1 |
Emphysema | D004646 | EFO_0000464 | J43 | — | 1 | — | — | — | 1 |
Obstructive lung diseases | D008173 | — | — | — | 1 | — | — | — | 1 |
Pulmonary emphysema | D011656 | — | J43 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Penile neoplasms | D010412 | — | C60 | — | — | — | — | 1 | 1 |
Prostatic neoplasms | D011471 | — | C61 | — | — | — | — | 1 | 1 |
Congenital heart defects | D006330 | — | Q24.9 | — | — | — | — | 1 | 1 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | — | 1 | 1 |
Drug common name | Sildenafil |
INN | sildenafil |
Description | Sildenafil, sold under the brand name Viagra, among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension.It is also sometimes used off-label for the treatment of certain symptoms in secondary Raynaud's phenomenon. It is unclear if it is effective for treating sexual dysfunction in women. It can be taken orally (swallowed by mouth), intravenously (injection into a vein), or sublingually (dissolved under the tongue). Onset when taken orally is typically within twenty minutes and lasts for about two hours.
|
Classification | Small molecule |
Drug class | phosphodiesterase type 5 inhibitors (PDE5) inhibitors: (PDE5) inhibitors containing a sulfonamide moiety |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 |
PDB | — |
CAS-ID | 139755-83-2 |
RxCUI | — |
ChEMBL ID | CHEMBL192 |
ChEBI ID | 9139 |
PubChem CID | 5212 |
DrugBank | DB00203 |
UNII ID | 3M7OB98Y7H (ChemIDplus, GSRS) |